Dekkers-found­ed in­vest­ment firm No­valis Life­Sciences rais­es $300M for sec­ond fund and adds to the team

Two years ago, life sci­ences VC No­valis Life­Sciences an­nounced that it had raised $85 mil­lion for its first fund, look­ing to in­vest in­to any­where be­tween 8 to 12 com­pa­nies “in var­i­ous seg­ments of the life sci­ence in­dus­try.” No­valis now wants to go big­ger, an­nounc­ing ear­li­er this week it raked in $300 mil­lion for No­valis Life­Sciences In­vest­ments II.

The New Hamp­shire-based VC, found­ed in 2017 by Gink­go Bioworks board chair­man and ex-Bay­er CEO Mar­i­jn Dekkers, plans to in­vest in­to any­where be­tween 10 and 15 more life sci­ence com­pa­nies.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER